ANI PHARMACEUTICALS, INC
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $760.1M
Liabilities Breakdown FY2022
Total Liabilities: $421.5M
Asset Breakdown
Total Assets: $760.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $48.2M | 6.3% |
| Accounts Receivable | $165.4M | 21.8% |
| Inventory | $105.4M | 13.9% |
| Property, Plant & Equipment | $43.2M | 5.7% |
| Goodwill | $28.2M | 3.7% |
| Intangible Assets | $251.6M | 33.1% |
| Other Assets | $118.0M | 15.5% |
Liabilities Breakdown
Total Liabilities: $421.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $29.3M | 7.0% |
| Long-Term Debt | $285.7M | 67.8% |
| Other Liabilities | $106.6M | 25.3% |